Targeted Therapeutics For Colon Cancer
4/06/2012
Anurag Singh, PhD, assistant professor in the Department of Pharmacology and Experimental Therapeutics at Boston University School of Medicine presented his recent work on targeted therapeutics for colon cancer at the American Association of Cancer Research Annual Meeting in Chicago, IL. Singh's seminar. It was featured in the "Late-Breaking Abstracts Mini-Symposium"...
Relatives Of Cancer Patients At Increased Risk For Cardiovascular Disease
4/06/2012
A current study shows that the risk for coronary heart disease and stroke increases by almost thirty per cent in a person whose partner has cancer. The cause is probably the negative stress to which the cancer patient's relative is exposed. We know that the relatives of chronically ill patients, especially cancer patients, have an increased risk of mental illness and depression...
Cetuximab After Colon Cancer Surgery - No Improvement In Disease-Free Survival
4/05/2012
A study published in the April 4 issue of JAMA reveals that patients who receive the drug cetuximab in addition to chemotherapy after undergoing surgery for stage III colon cancer do not have improved disease-free survival. According to the researchers, the chance of cure among patients who undergo surgery for removal of stage III colon cancer is 50%...
Womb Cancer Deaths Rise 20%, UK
4/05/2012
Deaths from womb cancer (cancer of the uterus) in the UK have gone up by nearly 20% in the last ten years. The trend follows a steep rise in the number of women diagnosed with cancer of the uterus, and is accompanied by improvements in survival rates, according to new figures from Cancer Research UK released on Thursday...
Less Intense Chemotherapy Better For Advanced Hodgkin's Lymphoma Patients
4/05/2012
According to results of a randomized trial, conducted by Dr. Andreas Engert, University Hospital of Cologne, Germany, and his team, lower doses of chemotherapy can treat individuals with advanced Hodgkin's lymphoma (a cancer affecting lymph tissue) more effectively. The study is published Online First by The Lancet...
Mammography Plus Additional Screening Better For Breast Cancer Detection
4/05/2012
A study published in the April 4 issue of JAMA reveals that ultrasound screening or magnetic resonance imaging (MRI) in addition to annual mammography increases breast cancer detection rates among women with an increased risk of breast cancer and dense breast tissue...
Height, BMI, Tied To Ovarian Cancer
4/05/2012
A new analysis of published and unpublished studies concludes that risk for ovarian cancer is associated with increasing height. It also finds that among women who have never used hormone therapy for the menopause, the risk for developing the disease is also tied to increasing body mass index, BMI, a measure of obesity...
Gene Sequencing Limited As Disease Predictor, Study
4/05/2012
If current trends continue, the cost of having one's genome analyzed will be comparable to that of the weekly supermarket bill. But will this give us the ability to predict which common diseases are likely to afflict us in the future? Well, according to a new study of twins that was published this week in Science Translational Medicine, the answer in most cases is likely to be no...
The Efficacy Of A Targeted Therapy Against Virus-Induced Lymphomas Impeded By Viral Replication
4/05/2012
Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma and primary effusion lymphoma (PEL). PELs are aggressive lymphomas with reported median survival time shorter than six months after diagnosis...
Key Mechanism Behind Lymphoma Targeted By New Compound
4/05/2012
Scientists at Fox Chase Cancer Center in Philadelphia have come one step closer to developing the first treatment to target a key pathway in lymphoma. The new findings was announced at the AACR Annual Meeting 2012. "It's an exciting time to be involved in lymphoma treatment and research," says study author Mitchell Smith, M.D., Ph.D., director of Lymphoma Service at Fox Chase...